Emmanuel Ekpor

Latent class analysis of the capacity of countries to manage diabetes and its relationship with diabetes-related deaths and healthcare costs

• Authors Details :  
• Samuel Akyirem,  
• Emmanuel Ekpor,  
• Charles Boakye Kwanin

Journal title : BMC Health Services Research

Publisher : Springer Science and Business Media LLC

Online ISSN : 1472-6963

Journal volume : 25

Journal issue : 1

135 Views Original Article

Background The prevalence of diabetes is escalating globally, underscoring the need for comprehensive evidence to inform health systems in effectively addressing this epidemic. The purpose of this study was to examine the patterns of countries’ capacity to manage diabetes using latent class analysis (LCA) and to determine whether the patterns are associated with diabetes-related deaths and healthcare costs. Methods Eight indicators of country-level capacity were drawn from the World Health Organization Global Health Observatory dataset: the widespread availability of hemoglobin A1C (HbA1c) testing, existence of diabetes registry, national diabetes management guidelines, national strategy for diabetes care, blood glucose testing, diabetic retinopathy screening, sulfonylureas, and metformin in the public health sector. We performed LCA of these indicators, testing 1–5 class solutions, and selecting the best model based on Bayesian Information Criteria (BIC), entropy, corrected Akaike Information Criteria (cAIC), as well as theoretical interpretability. Multivariable linear regression was used to assess the association between capacity to manage diabetes (based on the latent class a country belongs) and diabetes-related deaths and healthcare costs. Results We included 194 countries in this secondary analysis. Countries were classified into “high capacity” (88.7%) and “limited capacity” (11.3%) countries based on the two-class solution of the LCA (entropy = 0.91, cAIC = 1895.93, BIC = 1862.93). Limited capacity countries were mostly in Africa. Limited capacity countries had significantly higher percentage of their deaths attributable to diabetes (adjusted beta = 1.34; 95% CI: 0.15, 2.53; p = 0.027) compared to high capacity countries even after adjusting for income status and diabetes prevalence. Conclusions Our findings support the report by the Lancet commission on diabetes, which suggests that differences in diabetes outcomes among countries may be explained by variations in the capacity of and investments made in their health systems. Future studies should evaluate initiatives such as the WHO Global Diabetes Compact that are currently underway to improve the capacity of resource-limited countries.

Article DOI & Crossmark Data

DOI : https://doi.org/10.1186/s12913-024-12052-2

Article Subject Details

• Epidemiology
• Metabolic
• Public health
• Public health policy

Article Keywords Details

• healthcare cost
• latent class
• Deiabetes deaths
• Diabetes
• Diabetes management

Article File

Full Text PDF

Article References

• (1). International Diabetes Federation. IDF Diabetes Atlas | Tenth Edition [Internet] 2022.
• (2). Zurita-Cruz JN, Manuel-Apolinar L, Arellano-Flores ML, Gutierrez-Gonzalez A, Najera-Ahumada AG, Cisneros-González N. Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health Qual Life Outcomes. 2018;16:94. https://doi.org/10.1186/s12955-018-0906-y.
• (3). Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26:25–32. https://doi.org/10.1177/2047487319878371.
• (4). Yang JJ, Yu D, Wen W, Saito E, Rahman S, Shu X-O, et al. Association of Diabetes with all-cause and cause-specific mortality in Asia. JAMA Netw Open. 2019;2:e192696. https://doi.org/10.1001/jamanetworkopen.2019.2696.
• (5). GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of Disease Study 2021. Lancet 2024:S0140-6736(24)00476–8. https://doi.org/10.1016/S0140-6736(24)00476-8
• (6). Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10:14790. https://doi.org/10.1038/s41598-020-71908-9.
• (7). Chan JCN, Lim L-L, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2020;396:2019–82. https://doi.org/10.1016/S0140-6736(20)32374-6.
• (8). World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: Report of the 2021 global survey 2023.
• (9). Flood D, Seiglie JA, Dunn M, Tschida S, Theilmann M, Marcus ME, et al. The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults. Lancet Healthy Longev. 2021;2:e340–51. https://doi.org/10.1016/s2666-7568(21)00089-1.
• (10). Manne-Goehler J, Geldsetzer P, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med. 2019;16:e1002751. https://doi.org/10.1371/journal.pmed.1002751.
• (11). Naldi L, Cazzaniga S. Research Techniques made simple: latent class analysis. J Invest Dermatol. 2020;140:1676–80. .e1.
• (12). World Health Organization. Global Health Indicators 2021. https://www.who.int/data/gho/data/indicators (accessed August 27, 2024).
• (13). International Diabetes Federation. Mortality attributable to diabetes (20–79 y): Proportion of diabetes-related deaths in people under 60 y, % 2022. https://diabetesatlas.org/data/ (accessed August 27, 2024).
• (14). International Diabetes Federation. Diabetes-related health expenditure: Diabetes-related health expenditure per person, USD 2022. https://diabetesatlas.org/data/ (accessed August 27, 2024).
• (15). World Bank Group. WDI - The World by Income and Region. 2023. https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html (accessed August 27, 2024).
• (16). Linzer DA, Lewis JB. poLCA: an R package for polytomous variable latent class analysis. J Stat Softw. 2011;42:1–29.
• (17). Sinha P, Calfee CS, Delucchi KL. Practitioner’s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med. 2021;49:e63–79. https://doi.org/10.1097/CCM.0000000000004710.
• (18). Bak JCG, Serné EH, Kramer MHH, Nieuwdorp M, Verheugt CL. National Diabetes registries: do they make a difference? Acta Diabetol. 2021;58:267–78. https://doi.org/10.1007/s00592-020-01576-8.
• (19). World Health Organization. Registries and information systems for diabetes care in the WHO European Region: preliminary findings for consultation 2021.
• (20). Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of Diabetic patients. Biomark Insights. 2016;11:95–104. https://doi.org/10.4137/BMI.S38440.
• (21). Pearce I, Simó R, Lövestam-Adrian M, Wong DT, Evans M. Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review. Diabetes Obes Metab. 2019;21:467–78. https://doi.org/10.1111/dom.13550.
• (22). Nicholas A, Deji O. Invisible illness: the consequences of limited health insurance in Africa. Health Sci Rep. 2023;6:e1313. https://doi.org/10.1002/hsr2.1313.
• (23). Caraballo C, Valero-Elizondo J, Khera R, Mahajan S, Grandhi GR, Virani SS, et al. Burden and consequences of Financial Hardship from Medical bills among nonelderly adults with diabetes Mellitus in the United States. Circulation: Cardiovasc Qual Outcomes. 2020;13:e006139. https://doi.org/10.1161/CIRCOUTCOMES.119.006139.
• (24). Atun R, Davies JI, Gale EAM, Bärnighausen T, Beran D, Kengne AP, et al. Diabetes in sub-saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol. 2017;5:622–67. https://doi.org/10.1016/S2213-8587(17)30181-X.
• (25). Nuche-Berenguer B, Kupfer LE. Readiness of Sub-saharan Africa Healthcare Systems for the New Pandemic, diabetes: a systematic review. J Diabetes Res 2018;2018:e9262395. https://doi.org/10.1155/2018/9262395
• (26). Hunt D, Hemmingsen B, Matzke A, Varghese C, Hammerich A, Luciani S, et al. The WHO Global Diabetes Compact: a new initiative to support people living with diabetes. Lancet Diabetes Endocrinol. 2021;9:325–7. https://doi.org/10.1016/S2213-8587(21)00111-X.
• (27). Gregg E, Buckley J, Ali MK, Davies J, Flood D, Mehta R, et al. Improving Health outcomes of people with diabetes Mellitus: global target setting to reduce the Burden of Diabetes Mellitus by 2030. Lancet. 2023;401:1302–12. https://doi.org/10.1016/S0140-6736(23)00001-6.
• (28). Magliano D, Boyko EJ. IDF diabetes atlas. 10th edition. Brussels: International Diabetes Federation; 2021.

---

More Article by Emmanuel Ekpor